 Aortic Valve Stenosis
"Aortic Valve Stenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Descriptor ID |
D001024
|
| MeSH Number(s) |
C14.280.484.150 C14.280.955.249
|
| Concept/Terms |
Aortic Valve Stenosis- Aortic Valve Stenosis
- Aortic Valve Stenoses
- Stenoses, Aortic Valve
- Stenosis, Aortic Valve
- Valve Stenoses, Aortic
- Valve Stenosis, Aortic
- Aortic Stenosis
- Stenoses, Aortic
- Stenosis, Aortic
|
Below are MeSH descriptors whose meaning is more general than "Aortic Valve Stenosis".
Below are MeSH descriptors whose meaning is more specific than "Aortic Valve Stenosis".
This graph shows the total number of publications written about "Aortic Valve Stenosis" by people in this website by year, and whether "Aortic Valve Stenosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2009 | 5 | 0 | 5 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 6 | 0 | 6 | | 2013 | 2 | 1 | 3 | | 2014 | 7 | 0 | 7 | | 2015 | 6 | 1 | 7 | | 2016 | 9 | 2 | 11 | | 2017 | 22 | 3 | 25 | | 2018 | 6 | 3 | 9 | | 2019 | 12 | 0 | 12 | | 2020 | 10 | 0 | 10 | | 2021 | 14 | 0 | 14 | | 2022 | 19 | 2 | 21 | | 2023 | 5 | 0 | 5 | | 2024 | 6 | 1 | 7 | | 2025 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Aortic Valve Stenosis" by people in Profiles.
-
Joshi VA, Bucholz EM, Roll M, Rahman N, Kolte D, Davila C, Yeh RW, Cohen DJ, Waldo SW, Butala NM. Sex Differences in Stroke Frequency and Severity Following Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2025 Aug 05; 14(15):e041943.
-
Lalani C, Sharma RK, Sevilla-Cazes J, Kennedy K, Butala NM, Secemsky EA, Pinto D, Poulin MF, Laham R, Kolte D, Cohen DJ, Yeh RW. Outcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI Registry. Am J Cardiol. 2025 Sep 15; 251:18-24.
-
Batan D, Tseropoulos G, Kirkpatrick BE, Bishop C, Bera K, Khang A, Weiser-Evans M, Anseth KS. PTEN Regulates Myofibroblast Activation in Valvular Interstitial Cells Based on Subcellular Localization. Adv Biol (Weinh). 2025 Jul; 9(7):e2400540.
-
Gorashi RM, Baddour T, Chittle SJ, Félix Vélez NE, Wenning MA, Anseth KS, Mestroni L, Peña B, Guo P, Aguado BA. Y chromosome-linked UTY modulates sex differences in valvular fibroblast methylation in response to nanoscale extracellular matrix cues. Sci Adv. 2025 Mar 14; 11(11):eads5717.
-
Butala NM, Lalani C, Tale A, Song Y, Kolte D, Baron S, Strom J, Cohen DJ, Yeh RW. Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Circ Cardiovasc Interv. 2025 Jan; 18(1):e014592.
-
Sepucha K, Elmariah S, Valentine KD, Cavender MA, Chang Y, Devireddy CM, Dickert NW, Gama KD, Knoepke CE, Korngold E, Kumbhani DJ, Matlock DD, Messenger JC, Strong S, Thourani VH, Nathan A, Quader N, Brescia AA. The IMproving treatment decisions for Patients with AortiC stenosis Through Shared Decision Making (IMPACT SDM) Study: study protocol for a cluster randomized stepped wedge trial. Trials. 2024 Dec 18; 25(1):820.
-
Rabbani M, Fatehi Hassanabad A, Satriano A, Labib D, Lydell CP, Bristow M, Bizios A, Adams C, Alhussein MM, Dykstra S, Flewitt J, Rivest S, Kent W, Liang Z, Tao T, Howarth AG, Di Martino E, Fine NM, Chu MWA, White JA. Four-dimensional Cardiac Modelling of Multiphase Computed Tomography for Predicting Outcomes After Transcatheter Aortic Valve Replacement. Can J Cardiol. 2025 May; 41(5):959-969.
-
The E, Zhai Y, Yao Q, Ao L, Fullerton DA, Meng X. Molecular Interaction of Soluble Klotho with FGF23 in the Pathobiology of Aortic Valve Lesions Induced by Chronic Kidney Disease. Int J Biol Sci. 2024; 20(9):3412-3425.
-
Butala NM, Kapadia SR, Yeh RW, Cohen DJ. Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013698.
-
Butala NM, Kapadia SR, Secemsky EA, Gallup D, Kosinski AS, Vemulapalli S, Messenger JC, Yeh RW, Cohen DJ. Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry. Circ Cardiovasc Interv. 2024 Sep; 17(9):e013697.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|